Fundraising Fox
/Companies
Sign in

terrestrial

123 employees on LinkedIn · 4 known investors

Find your way into terrestrial

Sign up to see every warm intro you have to terrestrial

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the terrestrial team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.

BiotechDeep TechMedical Devices

Founders & leadership

RSRachel Sha
Rachel ShaCEORachel Sha is CEO of Terrestrial, which develops a dissolvable microarray patch platform for delivering therapies through the skin. She has experience in strategy, product development, business model innovation, and transaction management in life sciences and healthcare.

Investors · 4

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

The Engine Ventureslisted by The Engine VenturesCambridge

How we know: The Engine Ventures's portfolio page · Not right? Tell us

Ulu Ventureslisted by Ulu VenturesPalo Alto · $2M

How we know: Ulu Ventures's portfolio page · Not right? Tell us

Related companies · 1

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Companies working in the same space as terrestrial.

Frequently asked questions

What does terrestrial do?
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
Who are terrestrial's investors?
terrestrial's investors include Global Health Investment Corporation, RA Capital, The Engine Ventures, Ulu Ventures.